Response to *Nigella sativa* in Patients with Confirmed and Suspected COVID-19
Coronavirus Disease 2019 (COVID-19) has been widely spreading all over the world since the beginning of 2020. World Health Organization, on January 30th, 2020, declared the spread of COVID-19 to be a “public health emergency of international concern” (PHEIC). As of January 8th, 2021, 89,107,341 COVI...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | deu |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2020-03-01
|
| Series: | healthbook TIMES Das Schweizer Ärztejournal Journal Des Médecins Suisses |
| Online Access: | https://doi.org/10.36000/hbT.2021.01.001 |
| _version_ | 1797265920690749440 |
|---|---|
| author | Issa Rasheed Fetian Issa D Fitian Lukas Villiger Maged Darwish |
| author_facet | Issa Rasheed Fetian Issa D Fitian Lukas Villiger Maged Darwish |
| author_sort | Issa Rasheed Fetian |
| collection | DOAJ |
| description | Coronavirus Disease 2019 (COVID-19) has been widely spreading all over the world since the beginning of 2020. World Health Organization, on January 30th, 2020, declared the spread of COVID-19 to be a “public health emergency of international concern” (PHEIC). As of January 8th, 2021, 89,107,341 COVID-19 cases and 1,916,087 deaths due had been reported. The disease is transmitted via inhalation or contact with infected droplets. The incubation period ranges from 2 to 14 days and can reach up to 21 days. Many people are asymptomatic. The estimated fatality rate ranges from 2%−3%. Special molecular tests are being used to detect the virus in respiratory secretions. Elevated levels of C-reactive protein have been detected in the blood sample, while the white blood cell counts were considered normal. The computerized tomographic chest scan is usually abnormal even in those with no symptoms or mild disease. Current treatment options are essentially supportive, as the role of antiviral agents is yet to be established. Preventative measures can be utilized to slow the spread of infection, such as isolation of suspected cases or those with mild symptoms and strict infection control measures at hospitals. Though the virus is far more infectious than its two ancestors, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), 2019-nCoV has a lower mortality rate. To date, the impact of this pandemic is uncertain, and the global research community is working diligently to find a satisfactory therapy. To date, there is no approved oral treatment. |
| first_indexed | 2024-04-25T00:52:28Z |
| format | Article |
| id | doaj.art-1c8b5ebf48404605b8dd6d53f6ce070a |
| institution | Directory Open Access Journal |
| issn | 2673-8406 2673-8414 |
| language | deu |
| last_indexed | 2024-04-25T00:52:28Z |
| publishDate | 2020-03-01 |
| publisher | THE HEALTHBOOK COMPANY LTD. |
| record_format | Article |
| series | healthbook TIMES Das Schweizer Ärztejournal Journal Des Médecins Suisses |
| spelling | doaj.art-1c8b5ebf48404605b8dd6d53f6ce070a2024-03-11T15:46:36ZdeuTHE HEALTHBOOK COMPANY LTD.healthbook TIMES Das Schweizer Ärztejournal Journal Des Médecins Suisses2673-84062673-84142020-03-0111Response to *Nigella sativa* in Patients with Confirmed and Suspected COVID-19Issa Rasheed FetianIssa D FitianLukas VilligerMaged DarwishCoronavirus Disease 2019 (COVID-19) has been widely spreading all over the world since the beginning of 2020. World Health Organization, on January 30th, 2020, declared the spread of COVID-19 to be a “public health emergency of international concern” (PHEIC). As of January 8th, 2021, 89,107,341 COVID-19 cases and 1,916,087 deaths due had been reported. The disease is transmitted via inhalation or contact with infected droplets. The incubation period ranges from 2 to 14 days and can reach up to 21 days. Many people are asymptomatic. The estimated fatality rate ranges from 2%−3%. Special molecular tests are being used to detect the virus in respiratory secretions. Elevated levels of C-reactive protein have been detected in the blood sample, while the white blood cell counts were considered normal. The computerized tomographic chest scan is usually abnormal even in those with no symptoms or mild disease. Current treatment options are essentially supportive, as the role of antiviral agents is yet to be established. Preventative measures can be utilized to slow the spread of infection, such as isolation of suspected cases or those with mild symptoms and strict infection control measures at hospitals. Though the virus is far more infectious than its two ancestors, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), 2019-nCoV has a lower mortality rate. To date, the impact of this pandemic is uncertain, and the global research community is working diligently to find a satisfactory therapy. To date, there is no approved oral treatment.https://doi.org/10.36000/hbT.2021.01.001 |
| spellingShingle | Issa Rasheed Fetian Issa D Fitian Lukas Villiger Maged Darwish Response to *Nigella sativa* in Patients with Confirmed and Suspected COVID-19 healthbook TIMES Das Schweizer Ärztejournal Journal Des Médecins Suisses |
| title | Response to *Nigella sativa* in Patients with Confirmed and Suspected COVID-19 |
| title_full | Response to *Nigella sativa* in Patients with Confirmed and Suspected COVID-19 |
| title_fullStr | Response to *Nigella sativa* in Patients with Confirmed and Suspected COVID-19 |
| title_full_unstemmed | Response to *Nigella sativa* in Patients with Confirmed and Suspected COVID-19 |
| title_short | Response to *Nigella sativa* in Patients with Confirmed and Suspected COVID-19 |
| title_sort | response to nigella sativa in patients with confirmed and suspected covid 19 |
| url | https://doi.org/10.36000/hbT.2021.01.001 |
| work_keys_str_mv | AT issarasheedfetian responsetonigellasativainpatientswithconfirmedandsuspectedcovid19 AT issadfitian responsetonigellasativainpatientswithconfirmedandsuspectedcovid19 AT lukasvilliger responsetonigellasativainpatientswithconfirmedandsuspectedcovid19 AT mageddarwish responsetonigellasativainpatientswithconfirmedandsuspectedcovid19 |